Literature DB >> 35474555

Differentiate Thyroid Follicular Adenoma from Carcinoma with Combined Ultrasound Radiomics Features and Clinical Ultrasound Features.

Bing Yu1, Yanyan Li2, Xiangle Yu3, Yao Ai1, Juebin Jin1, Ji Zhang1, YuHua Zhang2, Hui Zhu2, Congying Xie1,4, Meixiao Shen5, Yan Yang6, Xiance Jin7,8.   

Abstract

Noninvasive differentiating thyroid follicular adenoma from carcinoma preoperatively is of great clinical value to decrease the risks resulted from excessive surgery for patients with follicular neoplasm. The purpose of this study is to investigate the accuracy of ultrasound radiomics features integrating with ultrasound features in the differentiation between thyroid follicular carcinoma and adenoma. A total of 129 patients diagnosed as thyroid follicular neoplasm with pathologically confirmed follicular adenoma and carcinoma were enrolled and analyzed retrospectively. Radiomics features were extracted from preoperative ultrasound images with manually contoured targets. Ultrasound features and clinical parameters were also obtained from electronic medical records. Radiomics signature, combined model integrating radiomics features, ultrasound features, and clinical parameters were constructed and validated to differentiate the follicular carcinoma from adenoma. A total of 23 optimal features were selected from 449 extracted radiomics features. Clinical and ultrasound parameters of sex (p = 0.003), interior structure (p = 0.035), edge (p = 0.02), platelets (p = 0.007), and creatinine (p = 0.001) were associated with the differentiation between benign and malignant follicular neoplasm. The values of area under curves (AUCs) of the radiomics signature, clinical model, and combined model were 0.772 (95% CI: 0.707-0.838), 0.792 (95% CI: 0.715-0.869), and 0.861 (95% CI: 0.775-0.909), respectively. A final corrected AUC of 0.844 was achieved for the combined model after internal validation. Radiomics features from ultrasound images combined with ultrasound features and clinical factors are feasible to differentiate thyroid follicular carcinoma from adenoma noninvasive before operation to decrease the unnecessary of diagnostic thyroidectomy for patients with benign follicular adenoma.
© 2022. The Author(s) under exclusive licence to Society for Imaging Informatics in Medicine.

Entities:  

Keywords:  Classification; Follicular neoplasm; Radiomics; Ultrasound

Mesh:

Substances:

Year:  2022        PMID: 35474555      PMCID: PMC9582092          DOI: 10.1007/s10278-022-00639-2

Source DB:  PubMed          Journal:  J Digit Imaging        ISSN: 0897-1889            Impact factor:   4.903


  32 in total

1.  Thyroid follicular neoplasms diagnosed by high-resolution ultrasonography with fine needle aspiration cytology.

Authors:  J D Lin; C Hsueh; T C Chao; H F Weng; B Y Huang
Journal:  Acta Cytol       Date:  1997 May-Jun       Impact factor: 2.319

2.  Ultrasonographic characteristics of thyroid nodules: prediction of malignancy.

Authors:  E Koike; S Noguchi; H Yamashita; T Murakami; A Ohshima; H Kawamoto; H Yamashita
Journal:  Arch Surg       Date:  2001-03

3.  Follicular adenoma and carcinoma of the thyroid gland.

Authors:  Christopher R McHenry; Roy Phitayakorn
Journal:  Oncologist       Date:  2011-04-11

4.  Sonographic features of thyroid follicular carcinoma in comparison with thyroid follicular adenoma.

Authors:  Ji-Zhen Zhang; Bing Hu
Journal:  J Ultrasound Med       Date:  2014-02       Impact factor: 2.153

5.  Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology.

Authors:  Zubair W Baloch; Seth Fleisher; Virginia A LiVolsi; Prabodh K Gupta
Journal:  Diagn Cytopathol       Date:  2002-01       Impact factor: 1.582

Review 6.  Follicular thyroid carcinoma.

Authors:  Manuel Sobrinho-Simões; Catarina Eloy; João Magalhães; Cláudia Lobo; Teresina Amaro
Journal:  Mod Pathol       Date:  2011-04       Impact factor: 7.842

Review 7.  Continuing controversies in the management of thyroid nodules.

Authors:  M Regina Castro; Hossein Gharib
Journal:  Ann Intern Med       Date:  2005-06-07       Impact factor: 25.391

8.  Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.

Authors:  K Boelaert; J Horacek; R L Holder; J C Watkinson; M C Sheppard; J A Franklyn
Journal:  J Clin Endocrinol Metab       Date:  2006-07-25       Impact factor: 5.958

9.  Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.

Authors:  Megan Rist Haymart; Daniel John Repplinger; Glen E Leverson; Diane F Elson; Rebecca S Sippel; Juan Carlos Jaume; Herbert Chen
Journal:  J Clin Endocrinol Metab       Date:  2007-12-26       Impact factor: 5.958

10.  Better understanding in the differentiation of thyroid follicular adenoma, follicular carcinoma, and follicular variant of papillary carcinoma: a retrospective study.

Authors:  Jung Hyun Yoon; Eun-Kyung Kim; Ji Hyun Youk; Hee Jung Moon; Jin Young Kwak
Journal:  Int J Endocrinol       Date:  2014-09-18       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.